HOME › DRUGS › MERCAPTOPURINE
ACTIVE SUBSTANCE / INN

MERCAPTOPURINE

Brand name(s): MERCAPTOPURINE, Xaluprine (previously Mercaptopurine Nova Laboratories), PURIXAN, Loulla, PURINETHOL
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
AUTHORISED
Leukemia, Lymphoid
NDA009053
ACTIVE SUBSTANCE
Mercaptopurine
REGULATORS
FDA · EMA
SPONSORS / MAH
NOVA LABS LTD, STASON PHARMS, HIKMA
TOTAL APPLICATIONS
5
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PURIXANNDA205919NOVA LABS LTDPrescription
PURINETHOLNDA009053STASON PHARMSPrescription
MERCAPTOPURINEANDA216418HIKMAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Xaluprine (previously Mercaptopurine Nova Laboratories)Lipomed GmbHAuthorised09/03/2012Leukemia, Lymphoid
LoullaOnly For Children PharmaceuticalsApplication withdrawnLeukemia, Lymphoid

FULL INTELLIGENCE ON MERCAPTOPURINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →